PHIO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. PHIO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PHIO has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

PHIO had negative earnings in the past year.
In the past year PHIO has reported a negative cash flow from operations.
PHIO had negative earnings in each of the past 5 years.
PHIO had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of PHIO (-69.13%) is worse than 62.10% of its industry peers.
PHIO's Return On Equity of -80.83% is in line compared to the rest of the industry. PHIO outperforms 51.43% of its industry peers.

		Industry Rank	Sector Rank
ROA	-69.13%
ROE	-80.83%
ROIC	N/A

ROA(3y)-110.57%

ROA(5y)-88.07%

ROE(3y)-133.2%

ROE(5y)-105.54%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

PHIO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

PHIO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, PHIO has more shares outstanding
PHIO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -15.77, we must say that PHIO is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -15.77, PHIO is doing worse than 80.00% of the companies in the same industry.
PHIO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-15.77

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

PHIO has a Current Ratio of 6.90. This indicates that PHIO is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PHIO (6.90) is better than 69.52% of its industry peers.
PHIO has a Quick Ratio of 6.90. This indicates that PHIO is financially healthy and has no problem in meeting its short term obligations.
PHIO has a better Quick ratio (6.90) than 69.71% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	6.9
Quick Ratio	6.9

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

PHIO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.87%, which is quite impressive.

EPS 1Y (TTM)81.87%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%71.43%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 23.91% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y75.37%

EPS Next 2Y35.74%

EPS Next 3Y23.91%

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PHIO. In the last year negative earnings were reported.
Also next year PHIO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.